Please assess the completion status of the following clinical trial:

Trial Title: Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~* Patients who are NOT diabetic, admitted with COPD who are likely to be prescribed corticosteroids as part of usual care with an admission glucose level (before steroids) between 6.1 and 11.1 mmol/l.~Exclusion criteria:~* Patients with diabetes mellitus~* Patients who are nil by mouth.~* Patients with severe co-morbid disease with an anticipated life expectancy of \< 6 months.~* Patients who are unable to provide informed consent.~* Age \<18 years.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Insulin Glulisine (Type: EXPERIMENTAL): Blood glucose monitoring and treatment of hyperglycaemia with insulin. Insulin to be with-held if pre meal blood glucose \< 4 mmol/l.
- 2 (Type: ACTIVE_COMPARATOR): Blood glucose monitoring for comparison with treatment arm (1)

Based on this trial design, predict the completion outcome and termination type (if applicable).